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ABSTRACT 
Objective (i) to explore the level of association between kinesiophobia and pain, 
disability, and quality of life in people with chronic musculoskeletal pain detected via 
cross-sectional analysis; (ii) to analyse the prognostic value of kinesiophobia on pain, 
disability, and quality of life in this population detected via longitudinal analyses.  
Design A systematic review of the literature including an appraisal of the risk of bias 
using the adapted Newcastle Ottawa Scale. A synthesis of the evidence was carried out.  
Data sources An electronic search of PubMed, AMED, CINAHL, PsycINFO, 
PubPsych, and grey literature was undertaken from inception to July 2017. 
Eligibility criteria for selecting studies Observational studies exploring the role of 
kinesiophobia (measured with the Tampa Scale for Kinesiophobia) on pain, disability, 
and quality of life in people with chronic musculoskeletal pain.  
Results Sixty-three articles (mostly cross-sectional) (total sample = 10,726) were 
included. We found strong evidence for an association between a greater degree of 
kinesiophobia and greater levels of pain intensity and disability, and moderate evidence 
between a greater degree of kinesiophobia and higher levels of pain severity and low 
quality of life. A greater degree of kinesiophobia predicts the progression of disability 
overtime, with moderate evidence. A greater degree of kinesiophobia also predicts 
greater levels of pain severity and low levels of quality of life at six months, but with 
limited evidence. Kinesiophobia does not predict changes in pain intensity. 
Summary/conclusions The results of this review encourage clinicians to consider 
kinesiophobia in their preliminary assessment. More longitudinal studies are needed, as 
most of the included studies were cross-sectional in nature. 
PROSPERO: CRD 42016042641 
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WHAT IS ALREADY KNOWN 
 There is no review on the association between kinesiophobia and pain and 
disability  
 A systematic review reporting this relationship has not been conducted. 
 The prognostic role of kinesiophobia on pain and disability is also unknown. 
 
WHAT ARE THE NEW FINDINGS 
 A greater degree of kinesiophobia at baseline predicts the progression of 
disability overtime.  
 A greater degree of kinesiophobia is associated with greater pain and disability. 
 A greater degree of kinesiophobia is associated with lower quality of life. 
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INTRODUCTION 
Most people suffer from musculoskeletal pain at least once in their lifetime [1]. As 
such, musculoskeletal pain is a highly prevalent and costly condition [1]. It is the 
second most common cause of disability in the general population [2]. There are many 
established factors (physical, biological, cognitive, behavioural, social, occupational) 
associated with poor prognosis following the onset of musculoskeletal pain [1,3] which 
helps to explain why many people do not recover after an episode of acute 
musculoskeletal pain often resulting in a downward spiral of negative physical, social, 
and psychological consequences [4]. Among the many biopsychosocial factors which 
contribute to the experience and impact of pain, negative or maladaptive psychological 
factors (e.g., fear) are amongst the most important [5–8]. 
Fear is considered to be a relevant factor in order to understand how acute pain becomes 
chronic for some people, and why pain and associated outcomes (e.g. disability) persist 
once the tissue damage has healed [9,10]. In this sense, the fear-avoidance (FA) model 
of pain is one of the frameworks which has received more empirical attention in order to 
explain the development and persistence of disability following an acute episode of 
musculoskeletal pain [9,11]. According to this model, individuals with a trait tendency 
to have fear and catastrophic thoughts in response to pain are more at risk of developing 
chronic musculoskeletal pain (CMP) after an injury compared to individuals who do not 
have this tendency [9]. These individuals overreact in response to actual or potential 
threats, developing avoidance behaviours (e.g. hypervigilance) which aim to prevent a 
new injury/re-injury [9]. Fear in relation to pain has been described with a variety of 
conceptual definitions among which pain-related fear, fear-avoidance beliefs, fear of 
movement, and kinesiophobia are the most commonly used [12]. 
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Physical inactivity is a potential factor for developing and maintaining CMP [13]. 
Whereas physical activity has positive benefits in decreasing pain and disability in some 
CMP conditions, e.g., lower limb osteoarthritis [14]. However, people with CMP often 
show fear of movement [15,16], which limits the adequate execution of a movement or 
exercise and leads to more sedentary behaviour [17]. Such fear imposes a barrier when 
exercise is prescribed as part of management resulting in significant clinical 
implications including reduced adherence to treatment and perseverance of a negative 
experience with pain [11]. 
Kinesiophobia (also known as fear of movement) is defined as an excessive, irrational, 
and debilitating fear to carry out a physical movement, due to a feeling of vulnerability 
to a painful injury or re-injury [18]. Both constructs are very similar [12], and 
essentially they have the same clinical relevance. Whilst kinesiophobia is usually 
assessed with the Tampa Scale of Kinesiophobia (TSK), there is not a specific tool to 
assess fear of movement [12]. The prevalence of kinesiophobia in persistent pain ranges 
from 50 to 70% [19,20]. It can be acquired through two forms: a direct aversive 
experience (e.g. pain or trauma) or social learning (observation and instruction) [21]. 
Kinesiophobia may be associated with pain and associated outcomes (disability and 
quality of life) in several ways. First, kinesiophobia alters how people move, possibly 
with the initial goal to avoid pain. It causes adjustments of motor behaviour which 
affects the performance of actions related to the management and control of pain and 
pain-related disability [22]. Second, the processing of pain and pain-related information 
in people with CMP could be related to how kinesiophobia is perceived [23]. Indeed, a 
greater degree of kinesiophobia predicts greater levels of pain [24].  
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The role of kinesiophobia in CMP has been explored extensively. In this regard, a large 
body of evidence has reported that kinesiophobia is associated with disability [25], pain 
[26–28], and quality of life [29]. Furthermore, longitudinal studies have shown that high 
levels of kinesiophobia at baseline, predict negative changes in quality of life [30], and 
positive changes in disability [31], and pain [30,32]. However, the evidence is 
inconsistent regarding the strength of the significance and the direction of the findings 
[33–37]. A synthesis of the evidence of the association between kinesiophobia and pain, 
disability, and quality of life would contribute to a better understanding and clarification 
of these relationships in patients with CMP. Moreover, examining the prognostic value 
of kinesiophobia on the aforementioned outcomes would facilitate a greater 
understanding of CMP mechanisms, and, thus permit better clinical decision-making. 
Clinical decision-making requires ongoing reconciliation of studies that provide 
different answers to the same question, and clinicians and researchers can also benefit 
from a summary where uncertainty remains [38].  
A systematic review of the literature will allow stronger conclusions to be reached 
compared to those achieved by any one study [39], and will facilitate readers who may 
have difficulties to capture and review all the evidence provided by primary studies. 
Hence, the aim of this systematic review was twofold: (i) to explore the level of 
association between kinesiophobia and pain, disability, and quality of life in people with 
CMP; (ii) to analyse the prognostic value of kinesiophobia on pain, disability, and 
quality of life in people with CMP. 
  
METHODS 
This review was conducted in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) statement [40]. The systematic 
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review protocol was registered at the International Prospective Register of Systematic 
Reviews (PROSPERO: CRD 42016042641). The initial intent of the study, as registered 
in PROSPERO, was to examine predictive studies only. This approach was abandoned 
since too few predictive studies existed and we determined that cross-sectional studies 
and case-control studies were also relevant to include in order to provide additional 
information on the level of association between kinesiophobia and outcomes related to 
CMP.     
Data Sources and Search Strategy 
The following electronic databases from the inception to February 2017 were searched: 
PubMed, AMED, CINAHL, PsycINFO, and PubPsych. An update of the search strategy 
was carried out in July 2017 to identify if any new potential studies had been published. 
A manual search of relevant eligible studies was also carried out. A sensitive search 
strategy using relevant search terms that were developed from Medical Subject 
Headings (MeSH), and keywords generated from the subject headings, were used 
(Appendix A). The following grey literature databases were explored: JBI COnNECT 
+, NHS Evidence, New York Academy of Medicine Grey Literature Report, Explore 
the British Library, TRIP database, National Guideline Clearinghouse, and Open Grey.  
Eligibility Criteria 
The PECOS (P-patient; E-exposure; C-comparator; O-outcome; S-study design) 
framework was followed to determine which studies to include in the present systematic 
review. Each study had to meet the following inclusion criteria:  
(i) Observational studies (cross-sectional, case-control and longitudinal studies) 
exploring the predictive role of kinesiophobia in people with CMP, and their 
associations with the outcomes described below. When prospective studies only 
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reported findings from the baseline assessment in sufficient detail, analyses between 
kinesiophobia and outcome measures were limited to the initial assessment and 
considered as cross-sectional studies. 
(ii) Studies whose participants were adults diagnosed with CMP, defined in this review 
as persistent or episodic pain lasting more than three months, around the axial skeleton 
(neck, low back, and/or pelvic) or peripheral joints (shoulder, elbow, wrist, knee, and/or 
ankle). In this regard, the ACCTION-APS Pain Taxonomy (AAPT) for chronic pain 
was used [41], including people with diagnoses of chronic myofascial pain, 
fibromyalgia, chronic widespread pain (e.g. chronic fatigue syndrome), rheumatoid 
arthritis, spondyloarthropathies, and those with a diagnosis of osteoarthritis. Although 
the AAPT for chronic pain does not consider spinal pain as part of the musculoskeletal 
pain group, we decided to include people with chronic axial musculoskeletal pain in the 
present review.  
(iii) Only studies measuring kinesiophobia with the Tampa Scale for Kinesiophobia 
(TSK) were included [12]. 
(iv) No restrictions were applied on participants’ gender, ethnicity, and follow-up 
duration (in case of longitudinal studies). 
(v) Studies recruiting participants from the general population, primary, secondary or 
tertiary care. 
(vi) Only articles written in English were included.  
(vii) Studies were only included if there was at least one association between 
kinesiophobia and one of the following outcome measures: pain, disability and/or 
quality of life. With regards to the pain construct, the authors of the present review 
recognise that the differences between pain intensity and pain severity are narrow. 
However, in order to facilitate the synthesis of results, we divided both constructs based 
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on a previous literature review [42] which showed that pain intensity is commonly 
measured with unidimensional instruments (e.g., the numerical rating scale (NRS)), 
whereas pain severity is mostly measured with multidimensional instruments (e.g., the 
multidimensional pain inventory (MPI)), where not only intensity of pain is taken into 
account.   
Exclusion criteria were as follows: 
(i) Studies of acute pain, subacute pain, and chronic non-musculoskeletal pain according 
to the AAPT. 
(ii) Studies where CMP was associated with a diagnosis of major psychiatric disorders.  
(iii) studies evaluating kinesiophobia in CMP attributed to previous fracture or 
exploring this factor before surgery or post-surgery. 
(iv) Studies analysing kinesiophobia in individuals with CMP after trauma. 
(v) Studies examining the role of kinesiophobia in experimental models of pain.  
(vi) Studies testing kinesiophobia in the context of a behavioural task or treatment (e.g., 
exposure in vivo). 
 (vii) Reviews, clinical studies, case reports, editorial, and abstracts.  
Study Selection 
First, two authors (JMC and ALS) carried out the screening of titles and abstracts. 
Second, the same authors checked the full text of the included manuscripts. Third, in 
case of any disagreement, a decision was made by consensus with the participation of a 
third author (DF). A short checklist was adapted to the present review and was used to 
guide the selection of relevant studies (see Appendix B) [43]. 
Data Extraction  
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The following relevant data from each study were extracted: study details (first author, 
year of publication), sample size, characteristics of participants (mean age, pain 
duration, pain condition), kinesiophobia measures, outcome (pain, disability, and 
quality of life) measures, duration of follow-up (in case of longitudinal studies), and 
study design. When necessary, an email was sent to the original authors to obtain 
further information regarding a study’s findings.  
Quality Assessment 
The risk of bias of each included study was evaluated using an adapted version of the 
Newcastle-Ottawa Scale (NOS) [44]. This adapted version includes four domains of 
risk of bias assessment: methods for selecting study participants (selection bias), 
methods to control for confounding (performance bias), statistical methods (detection 
bias), and methods of exposure and outcome assessment (information bias). Seven items 
compose the four domains. Each item is scored from zero (high risk) to three (low risk) 
points. Therefore, the maximum score for each study could be twenty-one points. Two 
researchers (JMC and ALS) were involved at this stage. When any disagreement did 
appear, a third researcher (DF) was consulted and a decision by consensus was carried 
out. Qualitative analysis of the evidence was carried out involving a rating system (the 
Modified Cochrane Back and Neck group) with five levels of scientific evidence [45]. 
The rating system was based on the methodological quality and the outcome of the 
studies: (i) strong evidence: consistent findings in two or more low risk of bias studies 
(score from 14 to 21 on NOS); (ii) moderate evidence: consistent findings in one low 
risk of bias study or two or more moderate risk of bias studies (score from 8 to 13 on 
NOS); (iii) limited evidence: consistent findings in one or more high risk of bias studies 
(score from 0 to 7 on NOS) or one moderate risk of bias study; (iv) lacking evidence: no 
published studies found; (v) conflicting evidence: inconsistent or contradictory findings 
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within a quality level. Due to the absence of a cut-off in the adapted NOS scale, the 
authors decided to divide the scores in three sections (mentioned above) according to 
the levels of evidence included in the Modified Cochrane Back and Neck Group Criteria 
(low 0-7 on NOS; moderate 8-13 on NOS; strong 14-21 on NOS).  
Statistical Analysis 
For the primary analysis, studies were grouped per outcomes: disability, pain, and 
quality of life. A meta-analysis could not be carried out due to the presence of 
heterogeneity in terms of participant’s age, sample size, pain condition, outcome 
measures, version of self-reported kinesiophobia questionnaire (e.g. TSK-11 or TSK-
17), statistical methods used, and study design in most of the studies potentially eligible 
for conducting a meta-analysis. Consequently, a descriptive quantitative analysis (the 
most relevant summary measure with a precision estimate) was provided for each study. 
For those studies that reported results with several degrees of adjustment for 
confounders in different models, we extracted the estimate from the model which 
showed the best adjustment.  
 
Results  
Study characteristics  
A total of 1,757 articles were identified through electronic databases, with 148 
additional studies identified through reference screening. Six hundred and forty-four 
titles and abstracts were screened with 345 full-text articles evaluated. The number of 
studies retrieved from each database and the number of studies excluded in each 
screening phase are shown in Supplementary Figure 1. The full reference of excluded 
studies in the last screening (n=282) is reported in Appendix C. The conflict of interests 
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of included studies are shown in Appendix D. Of these, 63 observational studies (eight 
longitudinal studies; fifty cross-sectional studies; and five case-control studies) with a 
total of 10,726 participants (chronic low back pain (CLBP)= 2,504; fibromyalgia (FM)= 
1,540; chronic neck pain (CNP)= 861; knee osteoarthritis (KOA)= 614; chronic 
whiplash associated-disorders (CWAD)= 475; chronic fatigue syndrome (CFS)= 385; 
ankylosing spondylitis (AS)= 194; chronic knee pain (CKP)= 97; mixed= 4,056) 
satisfied our inclusion criteria and were included in this review. In case of longitudinal 
studies, duration of follow-up ranged from three to twelve months. Outcomes measures 
were as follows: disability [15,16,25–32,34,37,46–86], pain (pain intensity [15,25–
29,31,34,36,37,46–49,51–53,55–57,59,60,64,66–69,72,76,77,79,80,83–85,87–91], and 
pain severity [15,30,32,82,92,93]), and quality of life [28–30,47,72,80,82,89,94,95]. 
The characteristics of the included studies are reported in Appendix E. Eight authors 
were contacted directly by email to gather any non-published data.  
Risk of bias 
The degree to which studies met the risk of bias criteria varied considerably. The risk of 
bias assessment of all included studies is presented in Appendix F. 
 
The role of kinesiophobia on pain intensity, pain severity, disability, and quality of life 
in CMP  
After analysing the quality of evidence for each outcome included in the present 
systematic review through the Adapted Cochrane Back and Neck Pain Group Criteria, 
the evidence was divided between strong and moderate for cross-sectional studies (see 
Table 1) and limited to moderate for longitudinal studies (see Table 2). The statistical 
results for the association between kinesiophobia and pain, disability, and quality of life 
(cross-sectional analysis) are presented in Appendix G, and the predictive value of 
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kinesiophobia on pain, disability, and quality of life (longitudinal analysis) are 
presented in Appendix H.  
 
 
Table 1. Modified Cochrane Back and Neck Pain Group criteria for overall level of 
evidence based on cross-sectional studies 
Outcome Nº Studies No. of participants Level of evidence 
Kinesiophobia (association with) 
Quality of life 8 1,426 Moderate (negative association) 
Disability 46 9,351 Strong (positive association) 
Pain intensity 38 6,806 Strong (positive association) 
Pain severity 4 767 Moderate (positive association) 
Note: strong evidence: consistent findings in two or more low risk of bias studies (score 
from 14 to 21 on NOS); moderate evidence: consistent findings in one low risk of bias 
study or two or more moderate risk of bias studies (score from 8 to 13 on NOS); limited 
evidence: consistent findings in one or more high risk of bias studies (score from 0 to 7 
on NOS) or one moderate risk of bias study; lacking evidence: no published studies 
found; conflicting evidence: inconsistent or contradictory findings within a quality 
level.  
 
Table 2. Modified Cochrane Back and Neck Pain Group criteria for overall level of 
evidence based on longitudinal studies 
Outcome Nº Studies No. of participants Level of evidence 
Kinesiophobia (association with) 
Quality of life 2 289 Limited (negative association) 
Disability 7 1,123 Moderate (positive association) 
Pain intensity 2 204 Conflicting (positive association) 
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Pain severity 2 331 Limited (positive association) 
Note: strong evidence: consistent findings in two or more low risk of bias studies (score 
from 14 to 21 on NOS); moderate evidence: consistent findings in one low risk of bias 
study or two or more moderate risk of bias studies (score from 8 to 13 on NOS); limited 
evidence: consistent findings in one or more high risk of bias studies (score from 0 to 7 
on NOS) or one moderate risk of bias study; lacking evidence: no published studies 
found; conflicting evidence: inconsistent or contradictory findings within a quality 
level.  
 
The association between kinesiophobia and pain in people with CMP (cross-sectional 
analysis) 
The association between kinesiophobia and pain intensity based on cross-sectional 
analyses was evaluated by thirty-eight studies. A total of twenty-one studies showed a 
significant association between a greater degree of kinesiophobia and greater levels of 
pain intensity [15,29,46,48,49,51,53,59,64,67–69,72,76,83–85,87–89,91]. There was no 
significant relationship between kinesiophobia and pain intensity in thirteen studies 
[25,34,36,37,47,52,55–57,60,77,79,90]. One study did not report statistical results about 
the association between kinesiophobia and pain intensity [80]. Finally, three studies 
showed inconsistency in the strength of the significance in their findings  [26–28]. 
Altuğ et al.[28] showed a non-significant association between kinesiophobia and pain 
intensity at rest, whereas this association was significant and positive during activity. 
Lamoth et al. [27] showed a non-significant association between kinesiophobia and 
anticipated pain, whereas this association was significant and positive with regards to 
actual pain. Lundberg et al. [26] showed a significant and positive association between 
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kinesiophobia and CLBP, although this association was non-significant when CLBP 
was diagnosed as non-specific CLBP. Overall the quality of the evidence was strong.  
The association between kinesiophobia and pain severity based on cross-sectional 
analyses was evaluated in four studies. Two studies showed a significant association 
between a greater degree of kinesiophobia and greater of levels of pain severity [82,92]. 
There was no significant relationship between kinesiophobia and pain severity in one 
study [93]. One study showed inconsistency in the strength of the significance in their 
findings [15]. Bränström et al. [15] showed a non-significant association between 
kinesiophobia and pain severity in men, whereas this association was significant and 
positive in women. Overall the quality of the evidence was moderate. 
The predictive value of kinesiophobia on pain in people with CMP (longitudinal 
analysis) 
The predictive value of kinesiophobia on pain intensity in people with CMP was 
explored in two studies based on longitudinal analyses [31,66]. Helminen et al. [31] 
reported that the degree of kinesiophobia at baseline did not predict changes in pain 
intensity at twelve months after adjusting for age, gender, educational level, 
comorbidities, body mass index, work status, marital status, and disease severity. Koho 
et al. [66] reported that kinesiophobia at baseline did not predict changes in pain 
intensity at twelve months but no covariates were reported. The overall quality of the 
evidence was conflicting.  
The predictive value of kinesiophobia on pain severity in people with CMP was 
explored in two studies based on longitudinal analyses [30,32]. Wong et al. [30] 
reported that baseline kinesiophobia significantly predicted positive changes in pain 
severity at six months, even when adjusted for sociodemographic factors, and pain 
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variables (number, duration, and intensity). Van den Houte et al. [32] did not report the 
predictive value of kinesiophobia on pain severity. The overall quality of the evidence 
was limited. 
The association between kinesiophobia and disability in people with CMP (cross-
sectional analysis) 
The association between kinesiophobia and disability was evaluated by forty-six studies 
based on cross-sectional analyses. A total of thirty studies showed a significant 
association between greater degree of kinesiophobia and greater levels of disability 
[25,27–29,34,46–56,59,64,65,67–69,72,75,76,78,82–84,86]. There was no significant 
relationship between kinesiophobia and disability in eleven studies 
[37,57,60,62,63,74,77,79–81,85]. One study did not report statistical results on the 
association between kinesiophobia and disability [58]. Finally, four studies showed 
inconsistency in the strength of the significance in their findings [15,26,61,73]. 
Bränström et al. [15] reported a significant and positive association between 
kinesiophobia and disability in women, whereas this association was non-significant in 
men. Heuts et al. [61] found a significant and positive association between 
kinesiophobia and disability when kinesiophobia was measured with the somatic focus 
subscale of TSK but not with the activity-avoidance subscale for TSK. Lundberg et al. 
[26] showed a significant and positive association between kinesiophobia and disability 
in CLBP, although this association was non-significant when CLBP was diagnosed as 
non-specific CLBP. De Moraes Vieira et al. [73] reported a significant and positive 
association between kinesiophobia and moderate-severe disability, whereas this 
association was non-significant when the level of disability was minimal. The overall 
quality of the evidence was strong. 
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The predictive value of kinesiophobia on disability in people with CMP (longitudinal 
analysis) 
The predictive value of kinesiophobia on disability in people with CMP was explored in 
seven studies based on longitudinal analyses [16,30–32,66,70,71]. A greater degree of 
kinesiophobia at baseline significantly predicted greater levels of disability immediately 
after the intervention [32], and at three [32], six [16,30], and twelve [31] months follow-
up, even when adjusted for age [30,31], gender [30,31], educational level [31], 
comorbidities [31], body mass index [31], pain variables (number, duration, severity, 
and intensity) [16,30], disability at baseline [16], work status [31], marital status [31], 
and disease severity [31]. One study [32] reported a significant and positive association 
between kinesiophobia at baseline and disability after the intervention at three months 
without adjusting for covariates. Furthermore, Lüning Bergsten et al. [70] found a 
significant and positive association between changes in kinesiophobia after intervention 
and changes in disability after intervention without adjusting for any covariates. 
However, the relationship between changes in kinesiophobia at six months and changes 
in disability at six months was not reported. On the other hand, Matos et al. [71] 
reported that kinesiophobia at baseline did not predict changes in disability at three 
months. No covariates were reported. Koho et al. [66]  also showed that kinesiophobia 
at baseline did not predict changes in disability at twelve months. No covariates were 
reported. The overall quality of the evidence was moderate.  
The association between kinesiophobia and quality of life in people with CMP (cross-
sectional analysis) 
The association between kinesiophobia and quality of life was evaluated in eight studies 
based on cross-sectional analyses. A total of three studies showed a significant 
association between a greater levels of kinesiophobia and lower levels of quality of life 
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[29,72,80]. There was no significant relationship between kinesiophobia and quality of 
life in one study [96]. Finally, four studies showed inconsistency in the strength of the 
in their findings [28,47,89,94]. Altuğ et al. [28] found a significant and negative 
association between kinesiophobia and quality of life according to general health, 
physical function, social function, roles restricted by physical function and bodily pain. 
However, this association was not significant according to the role restricted by mental 
function, vitality, and mental health. Askary-Ashtiani et al. [47] showed a significant 
and negative association between kinesiophobia and quality of life (physical function), 
although this association was not significant in relation to mental health. Larsson et al. 
[97] reported a significant and negative association between kinesiophobia and quality 
of life when health is poor, whereas this association was not significant when health was 
very good, good, and fair. Nijs and Thielemans [94] showed a significant and negative 
association between kinesiophobia and quality of life according to the role limitations 
due to physical problems, mental health, and general health perception. However, this 
association was not significant according to physical functioning, role limitations due to 
emotional problems, social functioning, bodily pain, and vitality. The overall quality of 
the evidence was moderate. 
The predictive value of kinesiophobia on quality of life in people with CMP 
(longitudinal analysis) 
The predictive value of kinesiophobia on quality of life in people with CMP was 
explored in two studies based on longitudinal analyses [30,95]. Wong et al. [30] 
reported that greater degree of kinesiophobia at baseline significantly predicted lower 
levels of quality of life at six months, even after being adjusted for sociodemographic 
factors, and pain variables (number, duration, and intensity). However, the relationship 
was only significant with respect to physical function. Orenius et al. [95] reported that 
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kinesiophobia at baseline did not predict changes in quality of life at twelve months. No 
covariates were reported. Moreover, the predictive value of changes in kinesiophobia at 
twelve months and changes in quality of life at twelve months was not reported. The 
overall quality of the evidence was limited. 
DISCUSSION 
The synthesis of the data from the included studies in this systematic review showed the 
following findings: For the cross-sectional analyses: (i) strong evidence of an 
association between a greater degree of kinesiophobia and greater levels of pain 
intensity and disability; (ii) moderate evidence for an association between a greater 
degree of kinesiophobia and greater levels of pain severity; (iii) moderate evidence for 
an association between greater levels of kinesiophobia and lower quality of life. For the 
longitudinal analyses: (i) a greater degree of kinesiophobia at baseline predicts the 
progression of disability overtime, with moderate evidence; (ii) a greater degree of 
kinesiophobia at baseline predicts greater levels of pain severity at a six month follow-
up, with limited evidence; (iii) greater levels of kinesiophobia at baseline predict lower 
quality of life at six months, with limited evidence; (iv) conflicting evidence was found 
in support of kinesiophobia as a predictor of changes in pain intensity. 
Comparison with other studies  
This is the first synthesis of the evidence evaluating the role of kinesiophobia on pain, 
disability, and quality of life in people with CMP through the analysis of both cross-
sectional and longitudinal studies.  Fear is a basic emotion, which appears as a reaction 
to a specific, identifiable, and imminent threat (e.g. a fall) [98]. It is constituted by three 
components: interpretation of the stimulus as threatening, increased sympathetic 
arousal, and defensive behaviour [99]. Escape behaviours are a defensive and adaptive 
response to stimulus (e.g., pain) in the short term (acute phase) [100], and they can 
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reduce fear levels. However, in the long term (chronic phase), this avoidance activity 
can become maladaptive. People with CMP are presumed to develop kinesiophobia 
[15,16]. They often avoid activities which are assumed to provoke a real or potential 
injury/re-injury, developing in turn, further physical inactivity [9]. This fear to carry out 
certain movements can cause a negative vicious cycle where people with CMP show 
greater levels of pain, disability and emotional distress [9], and as a result, poor quality 
of life [101]. Our results support this statement as we identified moderate and strong 
evidence of associations between a greater degree of kinesiophobia and greater levels of 
pain, greater levels of disability and poorer quality of life, and in addition, moderate 
evidence that a greater degree of kinesiophobia is a predictor of the progression of 
disability overtime. Other systematic reviews have evaluated the role of other constructs 
of fear in acute, subacute, and chronic pain [102–105]. Zale and Ditre [102] showed 
how pain-related fear is associated with more severe disability in different acute and 
chronic pain conditions. Wertli et al. explored the prognostic value of fear-avoidance in 
low back pain [104], and also its role as a mediator of the treatment efficacy in this 
population [103]. Their findings showed that fear-avoidance predicted the delay of 
recovery in acute and subacute low back pain, favouring the development of chronicity 
[104]. Furthermore, fear avoidance also predicted poor treatment responses in acute, 
subacute and early chronic low back pain [103]. Finally, Kroska [105] reported how 
fear-avoidance is correlated with pain intensity bidirectionally in chronic pain 
conditions through the analysis of 118 cross-sectional studies.  
Strengths and weaknesses of the study 
The present systematic review has several strengths and some limitations that should be 
mentioned. The strengths are as follows: first, the elaboration and registration of a pre-
specified protocol on PROSPERO; the use of the PRISMA checklist through the 
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development of this systematic review; the use of the NOS adapted checklist to evaluate 
the risk of bias of each included study, and the Modified Cochrane Back and Neck Pain 
Group Criteria to analyse the overall quality and strength of the evidence. Second, the 
inclusion of sixty-three articles with a total sample of 10,726 individuals with CMP 
exploring the role of kinesiophobia on pain, disability, and/or quality of life allows us to 
establish a general overview about the role of kinesiophobia in musculoskeletal pain 
chronicity. As a limitation, even though a long variety of MeSH terms, grey literature 
and a manual search were carried out, it is still possible that not all studies were 
identified. Heterogeneity was present between all included studies (in terms of 
population, outcome measures, pain conditions, statistical parameters, and study design) 
which limits the opportunity to establish comparisons between studies. Moreover, 
although mediation analysis should be primarily carried out with the aim of identifying 
causal mechanisms, in order to avoid possible inflation of the results [106], none of the 
included studies specifically evaluated the possible mediating effect of kinesiophobia in 
CMP, and confounding variables were not always explored in all included studies. This 
review assessed one specific construct of fear (kinesiophobia). Although this construct 
may share similar characteristics and have similar clinical relevance to other fear 
constructs (e.g., fear avoidance beliefs or fear of pain), they are not necessarily 
interchangeable, and readers should consider this when interpreting the results. We 
selected those studies using the TSK to measure kinesiophobia. Although the TSK has 
been shown to be the most extended tool to assess this construct [12], this may limit the 
interpretation of our results. We should also recognise several modifications from the 
initial protocol registered in PROSPERO (CRD 42016042641), as follows: (i) we 
decided to include cross-sectional and case-control studies, in order to provide 
information, not only on the prognostic value of kinesiophobia, but also on the level of 
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association between kinesiophobia and outcomes related to CMP; (ii) The Grading of 
Recommendations Assessment, Development and Evaluation (GRADE) and Risk of 
bias assessment of prognostic factor studies (QUIPS) were replaced by the adapted 
version of NOS and by the Modified Cochrane Back and Neck Pain Group Criteria. In 
our search strategy we used specific keywords related to pain, (e.g., chronic pain, low 
back pain), and did not use “pain” alone, so we may have missed useful studies. 
Moreover, we did not include the keyword “hip pain” in our search strategy, so we may 
have missed relevant studies here too. 
 
Clinical implications  
Kinesiophobia is known to be a barrier to rehabilitation adherence in different chronic 
pain conditions [23,107]. However, it is also considered to be a modifiable factor that 
may facilitate earlier achievement of pain relief and functional recovery [108]. In this 
sense, clinicians should need to identify the presence of kinesiophobia prior to the 
prescription of any intervention, e.g., exercise therapy, since its presence may require a 
different and more specific approach than standard rehabilitation programmes. 
Furthermore, although rather speculative, individuals with CMP showing a greater 
degree of kinesiophobia could be more inclined to search for biomedical explanations 
and solutions for their pain disorder, due to fear for carrying out exercise or to 
understand their pain from a biopsychosocial perspective [23], giving rise to more co-
morbid disorders [109]. In this context, kinesiophobia may cause frustration for both 
patients and therapists, negatively affecting their therapeutic relationship, and limiting 
rehabilitation efforts [109]. Therefore, ideally the presence of kinesiophobia should be 
detected during the first assessment, to plan biopsychosocial treatment strategies 
focused on the modification of kinesiophobia. This could be achieved through the 
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selection of functional goals, education to manage safe behaviours, and graded exposure 
to feared activities in the form of behavioural experiments (e.g. exposure in vivo) [9]. 
 
Future Research 
In future research: (i) further longitudinal studies are needed analysing prospectively the 
prognostic value and the mediating role of kinesiophobia in people with CMP; (ii) 
further experimental studies using cognitive-behavioural activities (e.g. learned 
movements) are warranted in order to manipulate kinesiophobia; (iii) experimental 
studies applying biopsychosocial approaches that methodically address and reduce 
kinesiophobia are required; (iv) studies exploring the role of kinesiophobia on 
rehabilitation adherence in CMP population are needed; (v) as CMP is a complex 
multifactorial condition, a number of factors (biological, biomechanical, occupational, 
contextual, environmental, psychological) besides kinesiophobia may be associated 
with the development and perpetuation of CMP. These factors should be considered 
during observational and experimental studies, for example through cluster analysis, 
and mediation analysis, to determine the importance of each factor.  
 
CONCLUSIONS 
This systematic review revealed that a greater degree of kinesiophobia is associated 
with greater levels of pain intensity, pain severity and disability, as well as lower quality 
of life, based on the analysis of cross-sectional studies. The analysis of the prognostic 
role of kinesiophobia showed that greater levels of kinesiophobia at baseline predict 
higher levels of disability, pain severity and lower quality of life at a six month follow-
up, while kinesiophobia does not predict changes in pain intensity. The results of this 
systematic review encourage clinicians to evaluate kinesiophobia in patients with CMP, 
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as the presence of kinesiophobia can impact on adherence to exercise therapy and may 
require specific management strategies such as the selection of functional goals, 
education to manage safe behaviours, and graded exposure to feared activities. Due to 
the low number of longitudinal studies found in this review, and the low level of the 
evidence attained in the analysis, causality was not firmly demonstrated, thus, further 
longitudinal studies are needed. 
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Figure legends 
Table 1 and Table 2. Modified Cochrane Back and Neck Pain Group criteria for 
overall level of evidence of cross-sectional and longitudinal studies 
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Note: strong evidence: consistent findings in two or more low risk of bias studies (score 
from 14 to 21 on NOS); moderate evidence: consistent findings in one low risk of bias 
study or two or more moderate risk of bias studies (score from 8 to 13 on NOS); limited 
evidence: consistent findings in one or more high risk of bias studies (score from 0 to 7 
on NOS) or one moderate risk of bias study; lacking evidence: no published studies 
found; conflicting evidence: inconsistent or contradictory findings within a quality 
level.  
Appendix A. Search Strategy  
Appendix B. A short question guide for the selection of relevant studies based on 
inclusion criteria 
Appendix C. Excluded studies in the last screening (n=282) 
 
Appendix D. Conflict of interest of included studies. 
Appendix E. Characteristics of included studies 
Note: CLBP: chronic low back pain; CWAD: chronic whiplash associated-disorders; 
CNP: chronic neck pain; CKP: chronic knee pain; CFS: chronic fatigue syndrome; FM: 
fibromyalgia; KOA: knee osteoarthritis; AS: Ankylosing spondylitis; VAS: visual 
analogue scale; RDQ: Roland and Morris Disability Questionnaire; RMDQ: Roland and 
Morris Disability Questionnaire; NRS: numeric rating scale; ODI: Oswestry disability 
index; SF-36 quality of life scale; PDI: Pain Disability Index; DRI: disability rating 
index questionnaire; MPI: the Multidimensional Pain Inventory; NDI: Neck Disability 
Index; WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index; 
QBPDS: the Quebec Back Pain Disability Scale; CFS-APQ: Chronic Fatigue Syndrome 
Activities and Participation Questionnaire; FIQR: Revised Fibromyalgia Impact 
Questionnaire; FIQR-pf: Revised Fibromyalgia Impact Questionnaire perceived 
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function; NPRS: the numeric pain rating scale; MPQ: the McGill Pain Questionnaire; 
RM: the Roland-Morris Low Back Pain and Disability Questionnaire; DPQ: the Dallas 
Pain Questionnaire; KOOS-ADL: the knee injury and osteoarthritis outcome scale- 
activities of daily living subscale; FIQ: Fibromyalgia Impact Questionnaire; DASH: the 
Disabilities of the Arm, Shoulder and Hand; BPI: the Brief Pain Inventory; CPG: 
Chronic Pain Grade questionnaire; ASQoL: the Ankylosing Spondylitis Quality of Life 
Questionnaire; SF-12 version 2: the Medical Outcome Study 12-item Short-Form 
Health Survey; PCS-12: physical component of the SF-12; MCS-12: mental component 
of the SF-12;  TSK-SF: tampa scale for kinesiophobia-somatic focus; TSK-AA: tampa 
scale for kinesiophobia-activity avoidance; BASFI: Bath Ankylosing Spondylitis 
Functional Index; RAND-36-Function: SF-36 item Health Survey RAND-36; C-S: 
cross-sectional; L: longitudinal. 
Appendix F. Assessment of risk of bias of included studies through the NOS. 
Note: the Newcastle-Ottawa Quality Assessment Scale: adapted version: A = Is the 
source population (cases, controls, cohorts) appropriate and representative of the 
population of interest?; B = Is the sample size adequate and is there sufficient power to 
detect a meaningful difference in the outcome of interest?; C = Did the study identify 
and adjust for any variables or confounders that may influence the outcome?; D = Did 
the study use appropriate statistical analysis methods relative to the outcome of 
interest?; E = Is there little missing data and did the study handle it accordingly?; F = Is 
the methodology of the outcome measurement explicitly stated and is it appropriate?; G 
= Is there an objective assessment of the outcome of interest?.  
 
Appendix G and H. Summary of the Statistical results of each outcome measure 
included in the systematic review. 
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Suppl Figure 1. Preferred Reporting Items for Systematic reviews and Meta-Analyses 
flow diagram of the conducted search. 
